Amy Compton-Phillips - 19 May 2025 Form 3/A - Amendment Insider Report for CVS HEALTH Corp (CVS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3/A - Amendment
Accepted by SEC
07 Nov 2025, 16:31:43 UTC
Original report date
27 May 2025
Next SEC filing
03 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Amy Compton-Phillips

Key filing fact

Amy Compton-Phillips filed Form 3/A - Amendment for CVS HEALTH Corp (CVS) on 07 Nov 2025.

Key facts

  • This page summarizes Amy Compton-Phillips's Form 3/A - Amendment filing for CVS HEALTH Corp (CVS).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Nov 2025, 16:31.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001741492 Primary reporting owner

Compton-Phillips Amy

Relationship
EVP, Chief Medical Officer
Address
ONE CVS DRIVE, WOONSOCKET
Signature
/s/ Amy Compton-Phillips
Signature date
07 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
35
Date
19 May 2025
Ownership
By Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares held in a living trust for the benefit of the Reporting Person that were not previously reported due to an error on the part of the Reporting Person's broker.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .